LQZ-7F, a survivin dimerization inhibitor, induces spontaneous apoptosis and synergizes with Docetaxel in prostate cancer cells. LQZ-7F dose-dependently inhibits survival of both PC-3 and C4-2 cells with IC50s of 2.99 and 2.47 µM, respectively[1].
Molecular Weight:
349.26
Purity:
97.13
CAS Number:
[354543-09-2]
Formula:
C14H7N9O3
Target:
Apoptosis,Survivin
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted